glp 1 and gastric emptying GLP-1 receptor agonists delayed emptying: implications for invasive cardiac interventions and surgery GLP-1 Agonist-Induced Delayed Gastric Emptying

These events stimulate the secretion of insulin, helping to compensate for insulin resistance triggered by new-onset diabetes. The drug also suppresses glucagon release by the pancreas, resulting in glucose-dependent reduction in plasma glucose and postprandial glucose by inhibiting hepatic glucose production and delaying gastric emptying. GLP-1s also act in brain regions associated with appetite and reward, reducing food intake and promoting weight loss

This property is well-documented in publications by Sikiric and colleagues

It is important to note that patients who fail to meet all of these risk factors (i.e., patients on stable doses without gastrointestinal symptoms) can still have delayed gastric emptying

Wegovy: side effects Wegovy and Contrave have some overlap in their potential side effects, such as nausea